Hello, everyone, and welcome back from the weekend. We hope the respite was relaxing enough to help you prepare for the usual routine that now resumes. Of course, this may be a relatively quiet week, given that this is a traditional vacation time. Nonetheless, we are busy undertaking our usual R&D which, of course, requires a cup of stimulation. Feel free to join us. Meanwhile, here are some tidbits to help you get started. Hope your day goes well...
Lilly's Effient Failed To Beat Plavix In Heat-To-Head MCS Study (Reuters)
Roche Makes Deal To Keep NJ Property Taxes Stable (The Record)
New Novartis Drug Shows Potential In Heart Failure (Reuters)
Fat-Bellied People At Higher Risk Of Death Than The Obese (Bloomberg News)
EMA Warns Pacira Over Manufacturing Problems (InPharma Technologist)
Battle Over Childhood Cancer Drugs In The UK (The Guardian)
FDA Asks Genzyme To Redo Lemtrada Application (Reuters)
Omnicare Agrees To Settle Whistleblower Lawsuit (Chicago Tribune)
Merck To Seek FDA Approval For Two Heart Drugs In 2013 (Reuters)
Lilly Wins Appeal Upholding Alimta Cancer Drug Patent (Bloomberg News)
FDA Asks J&J's DePuy To Recall Unused Customs Implants (Mass Device)
Teva Starts New Round Of Testing For MS Pill (Bloomberg News)
EirGen Pharma Objects To Waste Plant Next Door (Irish Times)
EDITOR'S NOTE: Please check this post for updates during the day
sunrise pic thx to benimoto on flickr